Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmberg, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmberg, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 24:419-420, 2001
© 2001 by the American Diabetes Association, Inc.

Screening for Diabetic Retinopathy

Paul Palmberg, MD, PHD

Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida

In this issue, Malone et al. (1) use their analysis of the retinal photographs taken in the Diabetes Control and Complications Trial (DCCT) to try to challenge the well-established dictum that it is not useful to perform early screening (<5 years duration) for diabetic retinopathy in juvenile-onset type 1 diabetes. I share their enthusiasm for preventing vision loss; however, in my judgment, the data do not support their challenge, but rather strongly support the current recommendation.

Screening examinations or any tests performed in medicine should only be done when the results have a reasonable probability of altering the treatment, when the risk-to-benefit ratio of undergoing the test is favorable for the individual patient, and when the cost-to-benefit ratio is competitive with other uses of health care dollars. Early screening for diabetic retinopathy in juvenile-onset type 1 diabetes fails on all three counts.

First, consider that not one of the 1,613 patients screened for the DCCT at <5 years duration of diabetes had proliferative retinopathy . . . [Full Text of this Article]

FOOTNOTES

References


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
R. M. Ehrlich
Response to Malone et al.
Diabetes Care, September 1, 2001; 24(9): 1698 - 1699.
[Full Text] [PDF]


Home page
Diabetes CareHome page
J. I. Malone
Response to Ehrlich
Diabetes Care, September 1, 2001; 24(9): 1699 - 1699.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.